Alvesco (ciclesonide) / Korea University Medical Center, Teijin, AstraZeneca, Covis Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
PROTECT-V, NCT04870333 / 2020-004144-28: PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Recruiting
2/3
5000
Europe
Niclosamide, Placebo, Ciclesonide, Sotrovimab
Cambridge University Hospitals NHS Foundation Trust, Life Arc, Kidney Research UK (KRUK), UNION therapeutics, Addenbrookes Charitable Trust, GlaxoSmithKline, National Institute for Health Research, United Kingdom
Covid19
07/24
12/24

Download Options